定义对SARS-CoV-2变种的儿科反应
Reanne M Ho1,2,3, Asha C Bowen2,3,4,5, Christopher C Blyth2,3,4
1Wal-yan Respiratory Research Centre, Telethon Kids Institute, University of Western Australia, Nedlands, WA, Australia.
Frontiers in immunology
|June 12, 2023
概括
儿童最初经历了较温和的COVID-19,但未来的变种可能会带来风险. 了解不同的免疫反应和炎症标志物对于保护易受伤害的儿童免受2019年冠状病毒严重疾病 (COVID-19) 的侵害至关重要.
科学领域:
- 儿科 儿科 儿科
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
背景情况:
- COVID-19大流行不成比例地影响了老年人,导致儿科研究的优先级下降.
- 与成年人相比,儿童对SARS-CoV-2感染的反应一般不那么严重.
研究的目的:
- 为了探索儿童COVID-19较温和的过程背后的因素.
- 评估新出现的SARS-CoV-2变种对儿科患者群体带来的风险.
- 确定保护儿童的关键研究缺口.
主要方法:
- 关于儿科COVID-19的现有文献的审查.
- 对影响病毒进入和儿童免疫反应的因素的分析.
- 检查炎症标志物,区分关键和非关键病例.
主要成果:
- 病毒入口受体表达和免疫反应的差异有助于轻微的儿科COVID-19.
- 未来的变种可能会增加儿童的严重疾病风险,特别是那些患有并发症的儿童.
- 在临界和非临界的儿科COVID-19病例之间存在不同的炎症特征.
结论:
- 虽然儿童受到COVID-19的严重影响较小,但需要保持警.
- 新出现的变种和并发症需要进一步研究小儿SARS-CoV-2病原体.
- 有针对性的研究对于保护弱势儿童免受严重的COVID-19后果至关重要.
相关概念视频
01:21Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
01:05Single Nucleotide Polymorphisms-SNPs
15.3K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.3K
01:21Acute Respiratory Failure-II
287
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
287